Form 4: Health Catalyst COO Daniel LeSueur Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
Health Catalyst's Chief Operating Officer, Daniel LeSueur, sold 5,209 shares of common stock at a price of $6.1863 per share on August 5, 2024, under a pre-arranged trading plan.
Summary
- Daniel LeSueur, the Chief Operating Officer of Health Catalyst, Inc. (HCAT), sold 5,209 shares of common stock on August 5, 2024.
- The sale was executed at a price of $6.1863 per share.
- Following the transaction, LeSueur directly owns 150,006 shares of Health Catalyst common stock.
- The sale was conducted under a pre-arranged trading plan adopted on March 7, 2024, in accordance with Rule 10b5-1.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to an insider stock sale under a pre-arranged trading plan. It doesn't convey any particularly positive or negative sentiment.
Industry Context
Insider sales are a common occurrence in publicly traded companies. The use of 10b5-1 trading plans allows insiders to sell shares over a period of time while avoiding concerns about trading on non-public information.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.
Key Dates
| Date | Description |
|---|---|
| 03/07/2024 | Date the Reporting Person adopted the written trading plan in accordance with Rule 10b5-1 |
| 08/05/2024 | Date of the stock sale transaction |
| 08/07/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.